INCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors.
Clinical trial NCT03272464 · TERMINATED
Trial details
- NCT number
- NCT03272464
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-29
- Primary completion
- 2019-07-24
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.